Whole genome sequencing shows sleeping sickness relapse is due to parasite regrowth and not reinfection

Evolutionary Applications

Volumn 9, Issue 2, 2016, Pages 381-393

  Richardson, Joshua B ^a   Evans, Benjamin ^a   Pyana, Patient P ^b   Van Reet, Nick ^c   Sistrom, Mark ^d   Büscher, Philippe ^c   Aksoy, Serap ^a   Caccone, Adalgisa ^a  

^a YALE UNIVERSITY   (United States)

^b Institut National de Recherche Biomedicale   (Congo)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug resistance; Human African trypanosomiasis; Melarsoprol; Population genomics; Trypanosoma brucei gambiense; Whole genome sequencing

Indexed keywords

EID: 84953774765     PISSN: 17524563     EISSN: 17524571     Source Type: Journal    
DOI: 10.1111/eva.12338     Document Type: Article

References (42)

1. Adzhubei, I. A., S. Schmidt, L. Peshkin, V. E. Ramensky, A. Gerasimova, P. Bork, A. S. Kondrashov et al. 2010. A method and server for predicting damaging missense mutations. Nature Methods 7:248-249.
2. Aksoy, S., A. Caccone, A. P. Galvani, and L. M. Okedi 2013. Glossina fuscipes populations provide insights for human African trypanosomiasis transmission in Uganda. Trends in Parasitology 29:394-406.
3. Alsford, S., S. Eckert, N. Baker, L. Glover, A. Sanchez-Flores, K. F. Leung, D. J. Turner et al. 2012. High-throughput decoding of antitrypanosomal drug efficacy and resistance. Nature 482:232-236.
4. Andrews, S. 2010. FastQC a quality control tool for high throughput sequence data. Available from http://www.bioinformatics.babraham.ac.uk/projects/fastqc/ (accessed on 24 September 2013).
5. Aslett, M., C. Aurrecoechea, M. Berriman, J. Brestelli, B. P. Brunk, M. Carrington, D. P. Depledge et al. 2010. TriTrypDB: a functional genomic resource for the Trypanosomatidae. Nucleic Acids Research 38:D457-D462.
6. Baker, N., L. Glover, J. C. Munday, D. Aguinaga Andres, M. P. Barrett, H. P. de Koning, and D. Horn 2012. Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes. Proceedings of the National Academy of Sciences of the United States of America 109:10996-11001.
7. Balmer, O., and A. Caccone 2008. Multiple-strain infections of Trypanosoma brucei across Africa. Acta Tropica 107:275-279.
8. Blum, J., S. Nkunku, and C. Burri 2001. Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis. Tropical Medicine and International Health 6:390-400.
9. Bringaud, F., N. Biteau, S. E. Melville, S. Hez, N. M. El-Sayed, V. Leech, M. Berriman et al. 2002. A new, expressed multigene family containing a hot spot for insertion of retroelements is associated with polymorphic subtelomeric regions of Trypanosoma brucei. Eukaryotic Cell 1:137-151.
10. Bromberg, Y., and B. Rost 2007. SNAP: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Research 35:3823-3835.
11. Carter, N. S., and A. H. Fairlamb 1993. Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature 361:173-176.
12. Cingolani, P., A. Platts, L. Wang le, M. Coon, T. Nguyen, L. Wang, S. J. Land et al. 2012. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 6:80-92.
13. Cong, Q., and N. V. Grishin 2012. MESSA: MEta-server for protein sequence analysis. BMC Biology 10:82.
14. Franco, J. R., P. P. Simarro, A. Diarra, J. Ruiz-Postigo, M. Samo, and J. Jannin 2012. Monitoring the use of nifurtimox-eflornithine combination therapy (NECT) in the treatment of second stage gambiense human African trypanosomiasis. Research and Reports in Tropical Medicine 3:93-101.
15. Graf, F. E., P. Ludin, T. Wenzler, M. Kaiser, R. Brun, P. P. Pyana, P. Buscher et al. 2013. Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol. PLoS Neglected Tropical Diseases 7:e2475.
16. Jackson, A. P., M. Sanders, A. Berry, J. McQuillan, M. A. Aslett, M. A. Quail, B. Chukualim et al. 2010. The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human African trypanosomiasis. PLoS Neglected Tropical Diseases 4:e658.
17. Jensen, B. C., D. Sivam, C. T. Kifer, P. J. Myler, and M. Parsons 2009. Widespread variation in transcript abundance within and across developmental stages of Trypanosoma brucei. BMC Genomics 10:482.
18. Jombart, T., and I. Ahmed 2011. adegenet 1.3-1: new tools for the analysis of genome-wide SNP data. Bioinformatics 27:3070-3071.
19. Jombart, T., S. Devillard, and F. Balloux 2010. Discriminant analysis of principal components: a new method for the analysis of genetically structured populations. BMC Genetics 11:94.
20. Langmead, B., and S. L. Salzberg 2012. Fast gapped-read alignment with Bowtie 2. Nature Methods 9:357-359.
21. Li, H., B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth et al. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25:2078-2079.
22. MacLeod, A., C. M. Turner, and A. Tait 1999. A high level of mixed Trypanosoma brucei infections in tsetse flies detected by three hypervariable minisatellites. Molecular and Biochemical Parasitology 102:237-248.
23. Maina, N., K. J. Maina, P. Maser, and R. Brun 2007. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate. Acta Tropica 104:84-90.
24. Manske, M., O. Miotto, S. Campino, S. Auburn, J. Almagro-Garcia, G. Maslen, J. O'Brien et al. 2012. Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature 487:375-379.
25. Maser, P., C. Sutterlin, A. Kralli, and R. Kaminsky 1999. A nucleoside transporter from Trypanosoma brucei involved in drug resistance. Science 285:242-244.
26. Matovu, E., J. C. Enyaru, D. Legros, C. Schmid, T. Seebeck, and R. Kaminsky 2001a. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda. Tropical Medicine and International Health 6:407-411.
27. Matovu, E., F. Geiser, V. Schneider, P. Maser, J. C. Enyaru, R. Kaminsky, S. Gallati et al. 2001b. Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy. Molecular and Biochemical Parasitology 117:73-81.
28. McKenna, A., M. Hanna, E. Banks, A. Sivachenko, K. Cibulskis, A. Kernytsky, K. Garimella et al. 2010. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Research 20:1297-1303.
29. Messer, P. W., and D. A. Petrov 2013. Population genomics of rapid adaptation by soft selective sweeps. Trends in Ecology and Evolution 28:659-669.
30. Moore, A., and M. Richer 2001. Re-emergence of epidemic sleeping sickness in southern Sudan. Tropical Medicine and International Health 6:342-347.
31. Mumba Ngoyi, D., V. Lejon, P. Pyana, M. Boelaert, M. Ilunga, J. Menten, J. P. Mulunda et al. 2010. How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness. Journal of Infectious Diseases 201:453-463.
32. Priotto, G., S. Kasparian, W. Mutombo, D. Ngouama, S. Ghorashian, U. Arnold, S. Ghabri et al. 2009. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet 374:56-64.
33. Pyana Pati, P., N. Van Reet, D. Mumba Ngoyi, I. Ngay Lukusa, S. Karhemere Bin Shamamba, and P. Buscher 2014. Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo. PLoS Neglected Tropical Diseases 8:e3212.
34. Pyana, P. P., I. Ngay Lukusa, D. Mumba Ngoyi, N. Van Reet, M. Kaiser, S. Karhemere Bin Shamamba, and P. Buscher 2011. Isolation of Trypanosoma brucei gambiense from cured and relapsed sleeping sickness patients and adaptation to laboratory mice. PLoS Neglected Tropical Diseases 5:e1025.
35. Schoville, S. D., A. Bonin, O. François, S. Lobreaux, C. Melodelima, and S. Manel 2012. Adaptive genetic variation on the landscape: methods and cases. Annual Review of Ecology, Evolution, and Systematics 43:23-43.
36. Shahi, S. K., R. L. Krauth-Siegel, and C. E. Clayton 2002. Overexpression of the putative thiol conjugate transporter TbMRPA causes melarsoprol resistance in Trypanosoma brucei. Molecular Microbiology 43:1129-1138.
37. Simarro, P. P., J. Franco, A. Diarra, J. A. Postigo, and J. Jannin 2012. Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis. Parasitology 139:842-846.
38. Sistrom, M., B. Evans, R. Bjornson, W. Gibson, O. Balmer, P. Maser, S. Aksoy, et al. 2014. Comparative genomics reveals multiple genetic backgrounds of human pathogenicity in the Trypanosoma brucei complex. Genome Biology and Evolution 6:2811-2819.
39. Smit, A. F. A., R. Hubley, and P. Green 2013-2015. RepeatMasker Open-4.0. Available from http://www.repeatmasker.org (accessed on 11 February 2014).
40. Stanghellini, A., and T. Josenando 2001. The situation of sleeping sickness in Angola: a calamity. Tropical Medicine and International Health 6:330-334.
41. Van der Auwera, G. A., M. O. Carneiro, C. Hartl, R. Poplin, G. Del Angel, A. Levy-Moonshine, T. Jordan et al. 2013. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Current Protocols in Bioinformatics 11:1-33.
42. Veitch, N. J., P. C. Johnson, U. Trivedi, S. Terry, D. Wildridge, and A. MacLeod 2010. Digital gene expression analysis of two life cycle stages of the human-infective parasite, Trypanosoma brucei gambiense reveals differentially expressed clusters of co-regulated genes. BMC Genomics 11:124.